Was 2023 Regeneron Pharmaceuticals, Inc.'s best revenue year?

No. Regeneron Pharmaceuticals, Inc.'s highest recorded revenue year was 2025 at $14.3B. In 2023, Regeneron Pharmaceuticals, Inc. reported $13.1B.

What was Regeneron Pharmaceuticals, Inc.'s highest ever annual revenue?

Regeneron Pharmaceuticals, Inc.'s highest ever annual revenue was $14.3B recorded in fiscal year 2025.

Regeneron Pharmaceuticals, Inc.

BiotechnologyFounded 1988

Reviewed by Swet Parvadiya

Last reviewed: July 2025

Explore Regeneron Pharmaceuticals, Inc.

Core profile pages, annual revenue records, and related research hubs for this company.

Regeneron Pharmaceuticals, Inc.

BiotechnologyFounded 1988

Reviewed by Swet Parvadiya

Last reviewed: July 2025

Annual Revenue

Regeneron Pharmaceuticals, Inc. Revenue in 2023

Q: What was Regeneron Pharmaceuticals, Inc.'s revenue in 2023?

Regeneron Pharmaceuticals, Inc. reported $13.1B in revenue for fiscal year 2023. Regeneron reported $13.1 billion in revenue for 2023, the earliest year shown here, with the EYLEA ophthalmology franchise and the Sanofi-partnered Dupixent driving the bulk of underlying sales.

FY2023 Revenue

$13.1B

Source: Annual report / company filing

Regeneron Pharmaceuticals, Inc. reported $13.1B in revenue for fiscal year 2023. In 2024, revenue increased to $14.2B.

Regeneron reported $13.1 billion in revenue for 2023, the earliest year shown here, with the EYLEA ophthalmology franchise and the Sanofi-partnered Dupixent driving the bulk of underlying sales.

Revenue by Year

FY2025 FY2024 FY2023

Regeneron Pharmaceuticals, Inc. Annual Revenue History

Year	Revenue	Net Income	YoY Change
FY2025	$14.3B	$4.4B	+0.7%
FY2024	$14.2B	—	+8.3%
FY2023	$13.1B	—	—

Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.

Next year →

FY2024: $14.2B

Explore Regeneron Pharmaceuticals, Inc.

Core profile pages, annual revenue records, and related research hubs for this company.